novus med are revolutionising patient care through the development of affordable and high quality medical devices
The NHS and the UK healthcare system faces unprecedented challenges. From our varied and extensive careers, it was apparent that some of the larger commercial suppliers to the NHS are sometimes limited in responding to these challenges. They often sell the same product but via different business models that do not impact on ‘real life costs’ to the customer. At times, offering fresh innovation or ‘cheaper’ technology conflicts with these organisations’ profitability pressures.
novus med sources technologies that have far reaching impacts on both healthcare economics and patient outcomes. We supply them in such a way that offers real cost savings to the healthcare system. A harmony of innovation, knowledge and service, all encapsulated by the aim of furthering medicine, while offering cost-savings to hospitals.
Our sales team is highly-trained and customer-focused. They are backed by an in-house service and support team which enables novus med to consistently provide excellent levels of customer satisfaction.
Accessing the UK market with a medical device requires careful planning and an ability to see the world through the eyes of all decision makers and stakeholders. Aside from the more formal requirements of regulatory clearance and reimbursement there is also the necessity to build evidence of economic value within NICE guidelines and comparative effectiveness, compared to existing technologies and products.
Companies can no longer assume that a potential market can be tapped once a device is registered and launched. It is crucial to incorporate a robust market access strategy that focuses on obtaining adequate and sustainable reimbursement prior to launching a new technology.
- 40 years of experience in the field of medical devices
- unique in securing key opinion leader engagement across all surgical specialties and can gain faster market entry for new products
- understands the dynamics and complex landscape for companies thinking about a medical product’s UK launch
- provides bespoke strategies in clinical and commerialisation plans